The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Company is investing more than €100 million in the expansion of the Halle site
VACUUBRAND has evolved rapidly in recent years, developing new innovative vacuum technology for laboratories, research and engineering
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
The AICVD tool can predict the risk of cardiovascular disease.
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
Subscribe To Our Newsletter & Stay Updated
